These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 6208414)

  • 1. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone.
    Helgeland A
    J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S474-6. PubMed ID: 6208414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in serum lipids during drug therapy of hypertension].
    Lohmann FW
    Wien Med Wochenschr; 1982; 132 Spec No 2():6-14. PubMed ID: 6132498
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in risk factors (cholesterol and triglycerides) in the treatment of high blood pressure with beta blockers and thiazide diuretics ].
    Ocón J; Doñate T; Yáñez C; del Río G
    Med Clin (Barc); 1982 Jun 16-30; 79(2):70-3. PubMed ID: 6126621
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of blood pressure and systolic time intervals by diuretics and beta-blockers in essential hypertension.
    González-Gómez A; Gamio Capestany F; Hernández-Cañero A; García-Barreto D
    Cor Vasa; 1983; 25(4):233-40. PubMed ID: 6139268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antihypertensive effect of a fixed combination of beta receptor blockaders and diuretics on the resting and exertion blood pressure of patients with essential hypertension].
    Franz IW
    Schweiz Med Wochenschr; 1980 Nov; 110(44):1616-22. PubMed ID: 6109375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glycemia increases during treatment of hypertension. 13 years' experience in the treatment of middle-aged men, randomized for treatment with beta blockers and diuretics].
    Válek J; Válková L; Storková H
    Cas Lek Cesk; 1996 May; 135(11):344-7. PubMed ID: 8706070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
    Kolloch R; Overlack A; Stumpe KO
    Ther Ggw; 1979 Oct; 118(10):1517-28. PubMed ID: 40314
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of beta-blocking agents, diuretics and pressidil (minoxidil) in severe arterial hypertension resisting other therapy].
    Angelino PF; Lavezzaro GC; Castaldo D
    Boll Soc Ital Cardiol; 1978; 23(9):1453-62. PubMed ID: 45249
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha 2-adrenoceptor agonists in the treatment of hypertension.
    Kaplan NM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S64-6. PubMed ID: 2417050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations on physiopathological approaches to the treatment of hypertension.
    Zanchetti A; Leonetti G; Morganti A; Terzoli L
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():1-9. PubMed ID: 28189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy in hypertension 1977. Empirical and rational viewpoints].
    Weidmann P; Fuss O
    Schweiz Med Wochenschr; 1978 Jan; 108(1):1-18. PubMed ID: 74092
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Lazzari P; Pasotti C; Corradi L
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S76-80. PubMed ID: 11527140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-blockers in the therapy of arterial hypertension in pregnancy].
    Fogari R; Zoppi A
    Minerva Ginecol; 1985 May; 37(5):201-8. PubMed ID: 2863788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.